Targeted therapy in acute myeloid leukaemia: current status and future directions
Published 2009 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeted therapy in acute myeloid leukaemia: current status and future directions
Authors
Keywords
-
Journal
EXPERT OPINION ON INVESTIGATIONAL DRUGS
Volume 18, Issue 4, Pages 433-455
Publisher
Informa Healthcare
Online
2009-04-01
DOI
10.1517/14728220902787628
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A limited number of 5-azacitidine cycles can be effective treatment in MDS
- (2008) Catharina Müller-Thomas et al. ANNALS OF HEMATOLOGY
- Single-agent lenalidomide induces complete remission of acute myeloid leukemia in patients with isolated trisomy 13
- (2008) T. A. Fehniger et al. BLOOD
- A decade of genome-wide gene expression profiling in acute myeloid leukemia: flashback and prospects
- (2008) B. J. Wouters et al. BLOOD
- Phase 1 study of the oral isotype specific histone deacetylase inhibitor MGCD0103 in leukemia
- (2008) G. Garcia-Manero et al. BLOOD
- Concomitant inhibition of Mdm2-p53 interaction and Aurora kinases activates the p53-dependent postmitotic checkpoints and synergistically induces p53-mediated mitochondrial apoptosis along with reduced endoreduplication in acute myelogenous leukemia
- (2008) K. Kojima et al. BLOOD
- A randomized study of clofarabine versus clofarabine plus low-dose cytarabine as front-line therapy for patients aged 60 years and older with acute myeloid leukemia and high-risk myelodysplastic syndrome
- (2008) S. Faderl et al. BLOOD
- Allogeneic stem cell transplantation in acute myeloid leukemia: a risk-adapted approach
- (2008) Tom Lodewyck et al. BLOOD REVIEWS
- Clofarabine combinations as acute myeloid leukemia salvage therapy
- (2008) Stefan Faderl et al. CANCER
- Combination of 5-azacytidine and thalidomide for the treatment of myelodysplastic syndromes and acute myeloid leukemia
- (2008) Azra Raza et al. CANCER
- Arsenic trioxide and low-dose cytarabine in older patients with untreated acute myeloid leukemia, excluding acute promyelocytic leukemia
- (2008) Gail J. Roboz et al. CANCER
- Treatment of core-binding-factor in acute myelogenous leukemia with fludarabine, cytarabine, and granulocyte colony-stimulating factor results in improved event-free survival
- (2008) Gautam Borthakur et al. CANCER
- Single-Cell Profiling Identifies Aberrant STAT5 Activation in Myeloid Malignancies with Specific Clinical and Biologic Correlates
- (2008) Nikesh Kotecha et al. CANCER CELL
- p53-Inducible Ribonucleotide Reductase (p53R2/RRM2B) Is a DNA Hypomethylation-Independent Decitabine Gene Target That Correlates with Clinical Response in Myelodysplastic Syndrome/Acute Myelogenous Leukemia
- (2008) P. A. Link et al. CANCER RESEARCH
- Histone Deacetylase Inhibitor Romidepsin Has Differential Activity in Core Binding Factor Acute Myeloid Leukemia
- (2008) O. M. Odenike et al. CLINICAL CANCER RESEARCH
- Leukemia-Associated Antigens Are Critical for the Proliferation of Acute Myeloid Leukemia Cells
- (2008) J. Greiner et al. CLINICAL CANCER RESEARCH
- Phase I and Pharmacokinetic Study of Bortezomib in Combination with Idarubicin and Cytarabine in Patients with Acute Myelogenous Leukemia
- (2008) E. C. Attar et al. CLINICAL CANCER RESEARCH
- A Phase I Study of Bexarotene, a Retinoic X Receptor Agonist, in Non-M3 Acute Myeloid Leukemia
- (2008) D. E. Tsai et al. CLINICAL CANCER RESEARCH
- A Phase I Study of the Pan Bcl-2 Family Inhibitor Obatoclax Mesylate in Patients with Advanced Hematologic Malignancies
- (2008) A. D. Schimmer et al. CLINICAL CANCER RESEARCH
- Tolerability, Pharmacodynamics, and Pharmacokinetics Studies of Depsipeptide (Romidepsin) in Patients with Acute Myelogenous Leukemia or Advanced Myelodysplastic Syndromes
- (2008) V. M. Klimek et al. CLINICAL CANCER RESEARCH
- Phase II Trial of Tipifarnib as Maintenance Therapy in First Complete Remission in Adults with Acute Myelogenous Leukemia and Poor-Risk Features
- (2008) J. E. Karp et al. CLINICAL CANCER RESEARCH
- Cotreatment with Vorinostat Enhances Activity of MK-0457 (VX-680) against Acute and Chronic Myelogenous Leukemia Cells
- (2008) W. Fiskus et al. CLINICAL CANCER RESEARCH
- Anticancer Immunotherapy in Combination with Proapoptotic Therapy
- (2008) Oystein Bruserud et al. CURRENT CANCER DRUG TARGETS
- A phase I clinical trial of the histone deacetylase inhibitor belinostat in patients with advanced hematological neoplasia
- (2008) Peter Gimsing et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Evaluation of Polo-like Kinase 1 inhibition on the G2/M checkpoint in Acute Myelocytic Leukaemia
- (2008) Christine Didier et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- In vivobiological effects of ATRA in the treatment of AML
- (2008) Anita Ryningen et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Effects of the aurora kinase inhibitors AZD1152-HQPA and ZM447439 on growth arrest and polyploidy in acute myeloid leukemia cell lines and primary blasts
- (2008) E. Walsby et al. HAEMATOLOGICA
- A phase I and pharmacokinetic study of XK469R (NSC 698215), a quinoxaline phenoxypropionic acid derivative, in patients with refractory acute leukemia
- (2008) Wendy Stock et al. INVESTIGATIONAL NEW DRUGS
- Low-Dose Interleukin-2 Immunotherapy Does Not Improve Outcome of Patients Age 60 Years and Older With Acute Myeloid Leukemia in First Complete Remission: Cancer and Leukemia Group B Study 9720
- (2008) Maria R. Baer et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I and Pharmacokinetic Study of YM155, a Small-Molecule Inhibitor of Survivin
- (2008) Anthony W. Tolcher et al. JOURNAL OF CLINICAL ONCOLOGY
- Immunotherapy for myeloid leukemias: current status and future directions
- (2008) K el-Shami et al. LEUKEMIA
- Hydroxyurea, azacitidine and gemtuzumab ozogamicin therapy in patients with previously untreated non-M3 acute myeloid leukemia and high-risk myelodysplastic syndromes in the elderly: results from a pilot trial
- (2008) Sucha Nand et al. LEUKEMIA & LYMPHOMA
- Phase I study of cladribine, cytarabine (Ara-C), granulocyte colony stimulating factor (G-CSF) (CLAG Regimen) and simultaneous escalating doses of imatinib mesylate (Gleevec) in relapsed/refractory AML
- (2008) Alison R. Walker et al. LEUKEMIA RESEARCH
- Gemtuzumab-ozogamicin in combination with fludarabine, cytarabine, idarubicin (FLAI-GO) as induction therapy in CD33-positive AML patients younger than 65 years
- (2008) Anna Candoni et al. LEUKEMIA RESEARCH
- Reversine, a novel Aurora kinases inhibitor, inhibits colony formation of human acute myeloid leukemia cells
- (2008) A. M. D'Alise et al. MOLECULAR CANCER THERAPEUTICS
- Mutations and Treatment Outcome in Cytogenetically Normal Acute Myeloid Leukemia
- (2008) Richard F. Schlenk et al. NEW ENGLAND JOURNAL OF MEDICINE
- Distinct microRNA expression profiles in acute myeloid leukemia with common translocations
- (2008) Z. Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Valproic Acid and All-Trans Retinoic Acid: Meta-Analysis of a Palliative Treatment Regimen in AML and MDS Patients
- (2008) Frauke Bellos et al. Oncology Research and Treatment
- Combination chemotherapy with low-dose cytarabine, homoharringtonine, and granulocyte colony-stimulating factor priming in patients with relapsed or refractory acute myeloid leukemia
- (2007) Wang-Gang Zhang et al. AMERICAN JOURNAL OF HEMATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started